Investors are tired of energy transition ‘jam tomorrow’ - FT中文网
登录×
电子邮件/用户名
密码
记住我
请输入邮箱和密码进行绑定操作:
请输入手机号码,通过短信验证(目前仅支持中国大陆地区的手机号):
请您阅读我们的用户注册协议隐私权保护政策,点击下方按钮即视为您接受。
FT商学院

Investors are tired of energy transition ‘jam tomorrow’

Patience is wearing thin, no matter how visionary the strategy
A Johnson Matthey factory in Poland. Excluding disposals, the company’s underlying business has since April 2021 burnt £135mn of cash, on estimates from shareholder Standard Investments

Should fossil fuel and industrial companies spend billions trying to build new, “cleaner” businesses? Or simply squeeze as much cash as possible from existing operations, even if they are in structural decline? This is one of the defining questions of the decade in many sectors.

Successful case studies backing up option A are becoming fewer and farther between. The 207-year-old British industrial group Johnson Matthey’s latest transformation shows how well-meaning ideas can turn into expensive misfires — as well as the dangers of becoming a “jam tomorrow” energy transition stock.

Standard Investments, Johnson Matthey’s largest shareholder, on Monday attacked the group for spending “significant capital” on “unproven” growth businesses. It is not hard to see why the group is coming under pressure: it trades about a fifth lower than rivals on a forward EV/ebitda basis on FactSet data.

Johnson Matthey is known for its catalytic converter business, which is still highly cash generative, despite pressures on the auto sector. Indeed, the company has said the division will generate at least £4.5bn of cash in the decade to 2031, £2bn of which has already been delivered. 

Trouble is, catalytic converters should — over time — become obsolete as consumers switch from combustion engines. Liam Condon, who took over as chief executive in 2022, has hence pursued a strategy which relies, in part, on a bet that other technologies, such as “clean” hydrogen, will take off.

This involves substantial upfront investment. Excluding disposals, Johnson Matthey’s underlying business has since April 1 2021 burnt £135mn of cash, on Standard’s estimates. Growth businesses aren’t solely to blame: Johnson Matthey is also investing in its traditional businesses, including building a more efficient refinery in China for critical materials including platinum.

The hydrogen division — which makes components for fuel cells and electrolysers — has consumed £310mn of cash since the 2022 fiscal year, says Standard. That’s a concern given the clean hydrogen industry is faltering.

Johnson Matthey may be hoping that shareholders will be willing to wait and see. Already, it has taken steps to stabilise the ship. It has delayed the start of production at a UK hydrogen components factory. Overall group capex, which totalled £1.1bn in the past three years, should reduce to £900mn over the next three. Cash flow generation should stabilise, reckons Panmure Liberum’s Lacie Midgley.

The problem is shareholders have already been burnt by Johnson Matthey’s expensive foray into cathodes for electric vehicle batteries under previous management, which resulted in a £363mn impairment and restructuring charge.

As others such as BP know only too well, patience is wearing thin with “cash tomorrow” energy transition promises — no matter how visionary the strategy.

nathalie.thomas@ft.com

版权声明:本文版权归FT中文网所有,未经允许任何单位或个人不得转载,复制或以任何其他方式使用本文全部或部分,侵权必究。

反弹的通胀与不耐烦的特朗普:凯文•沃什面临双重压力

美国参议院本周有望批准这位56岁的金融家接替杰伊•鲍威尔出任美联储主席。

伊朗战争推高燃气价格,印度工人纷纷逃离城市生活

伊朗战争推高了烹饪燃料价格,迫使印度许多务工人员返乡回村。

能源、军火与粮食:特朗普对伊战争日益沉重的代价

这场冲突正波及整个美国经济,造成了数千亿美元的产出损失。

肺纤维化生物科技公司Avalyn Pharma申请首次公开募股(IPO)

一家生物技术公司正开发可吸入剂型的已获批肺纤维化口服药,计划赴公开市场融资以支持其后期研发。
2天前

凯勒拉治疗学公司在生物技术领域创纪录的IPO中融资6.25亿美元

最新的生物科技公司首次公开募股创下历史新高。
2天前

法国将迎来最拥挤的大选角逐场:谁将取代马克龙?

左翼和中间阵营的分裂,助长了极右翼问鼎爱丽舍宫的希望。
设置字号×
最小
较小
默认
较大
最大
分享×